Novozymes AS (NSISb)

Currency in DKK
415.6
+2.9(+0.70%)
Closed·
Advertisement

Novozymes AS (NSISb) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy

Technical Indicators

Buy

Moving Averages

Buy

Summary:Buy

Moving Averages:BuyBuy: (7)Sell: (5)
Technical Indicators:BuyBuy: (5)Sell: (3)

Technical Indicators

Summary: BuyBuy: 5Neutral: 2Sell: 3
Aug 4, 2026 15:00 GMT
Name
Value
Action
RSI(14)48.995Neutral
STOCH(9,6)42.939Sell
STOCHRSI(14)100Overbought
MACD(12,26)-1.3Sell
ADX(14)40.151Buy
Williams %R-30.952Buy
CCI(14)27.861Neutral
ATR(14)2.3571Less Volatility
Highs/Lows(14)0.5357Buy
Ultimate Oscillator60.108Buy
ROC0.12Buy
Bull/Bear Power(13)-1.122Sell

Moving Averages

Summary: BuyBuy: 7Sell: 5
Aug 4, 2026 15:00 GMT
Name
Simple
Exponential
MA5
413.8
Buy
413.9
Buy
MA10
413.3
Buy
414.1
Buy
MA20
415.4
Buy
415.5
Buy
MA50
418.0
Sell
417.3
Sell
MA100
417.9
Sell
417.9
Sell
MA200
420.1
Sell
414.5
Buy

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic411.4412.1412.6413.3413.8414.5415
Fibonacci412.1412.6412.8413.3413.8414414.5
Camarilla412.8412.9413413.3413.2413.3413.4
Woodie's411.2412412.4413.2413.6414.4414.8
DeMark's--412.4413.2413.6--

FAQ

Is Novozymes AS (NSISb) a Buy or Sell, from a Technical Analysis Perspective?

Based on moving averages and other technical indicators, today's Novozymes AS buy/sell signal is Sell.

What Do The Current Moving Averages for Novozymes AS (NSISb) Show?

The moving averages for Novozymes AS show a Neutral outlook, considering moving averages ranging from MA5 to MA200, with 6 Buy signals and 6 Sell signals.

What Do Today's Technical Indicators for Novozymes AS Show?

The technical indicators for Novozymes AS are in a Sell position based on daily analysis, with 3 signals on buy indicators and 6 sell signals.

What Is Novozymes AS (NSISb)'s 14-Day RSI?

The current Relative Strength Index (RSI) of NSISb over the 14-day period is 48.995, which suggests that the stock is a Neutral.

What Is Novozymes AS (NSISb)'s MACD?

NSISb's MACD (Moving Average Convergence/Divergence) is -1.300, which suggests that the stock is a Sell.

What Is Novozymes AS (NSISb)'s 5-Day Moving Average?

NSISb's 5-day moving average is 413.8, suggesting that the stock is a Buy.

What Is Novozymes AS (NSISb)'s 50-Day Moving Average?

NSISb's 50-day moving average is 418.0, suggesting that the stock is a Sell.

What Is Novozymes AS (NSISb)'s 200-Day Moving Average?

NSISb's 200-day moving average is 420.1, suggesting that the stock is a Sell.

What Is the Fibonacci Pivot Point Performance Value for Novozymes AS (NSISb)?

The Fibonacci pivot point performance value for NSISb is 413.3.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.